<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:department>Institute of Membrane &amp; Systems Biology</gtr:department><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C77C5FB8-7E11-4011-8E67-EF9B41BFC011"><gtr:id>C77C5FB8-7E11-4011-8E67-EF9B41BFC011</gtr:id><gtr:firstName>Lin-Hua</gtr:firstName><gtr:surname>Jiang</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FC517317%2F1"><gtr:id>B4B6D9E9-CCB0-408D-9B71-DD42C41EBF20</gtr:id><gtr:title>Molecular mechanisms of inhibition of P2X7 receptor by novel antagonists and activation by ADP-ribosylating ectoenzymes</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/C517317/1</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>The P2X7 receptor ion channel is an integral membrane protein which has little or no precedent in terms of the molecular and cellular basis of its action. These ion channels are gated by extracellular ATP and are primarily expressed on antigen-presenting immune cells where they are rapidly up-regulated and activated in the initial response to inflammatory stimuli. They couple to rapid release of the pro-inflammatory cytokine, interleukin-1beta in activated macrophage and P2X7-deficient mice show reduced inflammatory responses. These findings have excited much interest in immune cell biology and drug development research as a promising target to treat inflammatory diseases, particularly arthritis. Equally exciting at the level of fundamental biological processes, P2X7 receptors are unique ion channels in that they couple directly not only to cation/calcium flux but also to rapid alterations in cell and mitochondrial morphology (membrane blebbing, phosphatidylserine exposure, microvesicle shedding, mitochondrial swelling with depolarisation). Such phenomena previously have been associated with active cell death (apoptosis) but brief activation of the P2X7R induces these events without subsequent cell death. Much work in the past 5 years has begun to delineate signal transduction pathways and potential physiological roles for these cellular events but a glaring lack of information persists in regard to mechanisms underlying agonist binding and activation of this receptor. Such information is of fundamental biological interest because the pharmacology of this receptor is as unusual as is its cell biology. Two recent advances provide new opportunities to delineate molecular mechanisms of these ectodomain actions at the P2X7 receptor: the development of high affinity, selective antagonists and the discovery that this receptor is activated not only by extracellular ATP but also by ADP ribosylation. ADP ribosylation of the P2X7 receptor results from activatin of specific ADP-ribosylating ectoenzymes (ARTs) by extracellular NAD+. Specific methods are to study wild-type and mutant P2X7 receptors expressed alone or co-expressed with mammalian ARTs in HEK293 cells. We will (1) make point mutations and/or chimeric constructs in the ectodomain of P2X7, (2) use radio-labelled antagonists in ligand-binding studies, (3) measure membrane currents, membrane blebbing, cytoplasmic and mitochondrial calcium, annexin-V binding and YPORO-1 fluorescence, in quantitative pharmacological and biophysical experiments, (4) perform immunoprecipitation, blue native and 2D gel electrophoresis, and GST fusion protein pull-down assays, and (5) use time-lapse confocal microscopy of GPF and MRFP-tagged P2X7Rs and ARTs. These combined approaches will allow us to achieve our main objective which is to determine the molecular mechanisms underlying the actions on P2X7 receptors by these new selective receptor antagonists and the novel agonist, NAD-ART. These studies are also likely to identify residues forming the ligand binding motif of this protein and to provide tools for use in protein purification. Joint with BB/C517292/1</gtr:technicalSummary><gtr:fund><gtr:end>2009-09-14</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2006-05-15</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>208049</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sheffield</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>P2X7 receptors</gtr:description><gtr:id>5664B3F5-4E55-49FD-9714-2B5A6B3EB8E6</gtr:id><gtr:impact>(1) Stokes, L., Jiang, L.-H., Alcaraz, L., Bowers, K., Fagura, M., Furber M., Mortimore, M., Lawson, M., Theaker, J., Laurent, C., Braddock, M. and Surprenant, A. (2006) Characterization of a selective and potent antagonist of human P2X7 receptor, AZ11645373. British Journal of Pharmacology 149: 880-887 
(2) Liu, X., Surprenant, A., Mao, H.J., Roger, S., Xia, R., Bradley, H. and Jiang, L-H. (2008) Identification of key residues coordinating functional inhibition of P2X7 receptors by zinc and copper. Molecular Pharmacology 73: 252-259 
(3) Liu, X., Ma, W., Surprenant, A. and Jiang, L.-H. (2009) Identification of extracellular domain residues of rat P2X7 receptor involved in functional inhibition by acidic pH. British Journal of Pharmacology 156: 139-142 
(4) Bradley, H.J., Liu, X., Collins, V., Owide, J., Goli, G.R., Smith, M., Surprenant, A., White, S.J. and Jiang, L.-H. (2010) Identification of an intracellular microdomain of the P2X7 receptor that is crucial in basolateral membrane targeting in epithelial cells. FEBS Letters 584: 4740-4744 
(5) Roger, S., Mei, Z., Baldwin, J.M., Bradley, H., Dong, L., Baldwin, S.A., Surprenant, A. and Jiang, L.-H. (2010) Single nucleotide polymorphisms that were identified in affective mood disorders affect ATP-activated P2X7 receptor functions. Journal of Psychiatric Research 44: 347-355</gtr:impact><gtr:partnerContribution>contributed to the research we published</gtr:partnerContribution><gtr:piContribution>Collaborated with Professor A Surprenant</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>150048</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Research Training Fellowship</gtr:department><gtr:description>Wellcome Trust doctoral training</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:fundingRef>099758/Z/12/Z</gtr:fundingRef><gtr:id>AD8A1FAA-C580-492C-B90E-2A6D0CF540AB</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>56000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC doctoral training programme</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>19998C32-DF99-44FC-92B8-5D42719739E3</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The research provides an better understanding of the molecular mechanisms underpinning P2X7-mediated physiological functions and particularly human diseases. In addition, the structural and molecular mechanisms are useful knowledge for rationalizing the drug discovery approaches to this increasingly attractive drug target (P2X7) for the pharmaceutical sector.</gtr:description><gtr:id>B71D4C1B-23A7-4A6E-A4CD-EE6A1E7F1A76</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:sector>Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>The research has identified (1) the distinctive actions of a novel chemical on the human versus non-human P2X7 receptors; (2) the molecular mechanism by which disease-associated mutations in the human P2X7 receptors alter the receptor function; (3) the molecular basis underpinning the inhibitory of actions by trace metal ions on the P2X7 receptors.</gtr:description><gtr:exploitationPathways>(1) The novel chemical has been widely used since as the human P2X7 antagonists in preclinical studies of the physiological and pathological functions of the P2X7 receptors; 
(2) the molecular mechanisms by which disease-associated mutations alter the P2X7 receptor have been used to better understand how the causative relationships of mutations and diseases;
(3) the identification of the molecular basis of the inhibition by trace mental ions provides a better understanding of how they modulate the receptor-mediated functions.</gtr:exploitationPathways><gtr:id>D5D7DCD5-6BE1-43A0-9411-C79F289599E6</gtr:id><gtr:sectors><gtr:sector>Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/162056AE-363E-41A9-B62B-94D10FC1648B"><gtr:id>162056AE-363E-41A9-B62B-94D10FC1648B</gtr:id><gtr:title>New structure enlivens interest in P2X receptors.</gtr:title><gtr:parentPublicationTitle>Trends in pharmacological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/26c4fcbc9afbffeae0673947ddac2ead"><gtr:id>26c4fcbc9afbffeae0673947ddac2ead</gtr:id><gtr:otherNames>Browne LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0165-6147</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/24303AE7-37CA-4B71-911A-AEDEB7541322"><gtr:id>24303AE7-37CA-4B71-911A-AEDEB7541322</gtr:id><gtr:title>Identification of key residues coordinating functional inhibition of P2X7 receptors by zinc and copper.</gtr:title><gtr:parentPublicationTitle>Molecular pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/42f7c7c6107a6cd7198876022cb295cf"><gtr:id>42f7c7c6107a6cd7198876022cb295cf</gtr:id><gtr:otherNames>Liu X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0026-895X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9D6284AF-F24A-48F6-B752-CDBB6AC1E59C"><gtr:id>9D6284AF-F24A-48F6-B752-CDBB6AC1E59C</gtr:id><gtr:title>Residues 155 and 348 contribute to the determination of P2X7 receptor function via distinct mechanisms revealed by single-nucleotide polymorphisms.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/de174d17e66c432ad3ad6af74e2bd039"><gtr:id>de174d17e66c432ad3ad6af74e2bd039</gtr:id><gtr:otherNames>Bradley HJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8E860E72-17EA-46DE-A108-FA250F3364B3"><gtr:id>8E860E72-17EA-46DE-A108-FA250F3364B3</gtr:id><gtr:title>Pharmacological properties of the rhesus macaque monkey P2X7 receptor.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/de174d17e66c432ad3ad6af74e2bd039"><gtr:id>de174d17e66c432ad3ad6af74e2bd039</gtr:id><gtr:otherNames>Bradley HJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CCA9BF23-8C9B-452E-8D42-030A53C93BD9"><gtr:id>CCA9BF23-8C9B-452E-8D42-030A53C93BD9</gtr:id><gtr:title>Identification of the amino acid residues in the extracellular domain of rat P2X(7) receptor involved in functional inhibition by acidic pH.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/42f7c7c6107a6cd7198876022cb295cf"><gtr:id>42f7c7c6107a6cd7198876022cb295cf</gtr:id><gtr:otherNames>Liu X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D196C36D-E060-4964-A800-A22599128243"><gtr:id>D196C36D-E060-4964-A800-A22599128243</gtr:id><gtr:title>Characterization of a selective and potent antagonist of human P2X(7) receptors, AZ11645373.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b4902ce19cc98cbc165b92b48d59b80d"><gtr:id>b4902ce19cc98cbc165b92b48d59b80d</gtr:id><gtr:otherNames>Stokes L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FD63CA6B-2072-4D75-859B-8C30B9116E35"><gtr:id>FD63CA6B-2072-4D75-859B-8C30B9116E35</gtr:id><gtr:title>Single nucleotide polymorphisms that were identified in affective mood disorders affect ATP-activated P2X7 receptor functions.</gtr:title><gtr:parentPublicationTitle>Journal of psychiatric research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8b12ab08115b0843babff16a09d4714f"><gtr:id>8b12ab08115b0843babff16a09d4714f</gtr:id><gtr:otherNames>Roger S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3956</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CAE7A848-3B6A-4D53-9145-EEE9A7B1E622"><gtr:id>CAE7A848-3B6A-4D53-9145-EEE9A7B1E622</gtr:id><gtr:title>Understanding the roles of the P2X7 receptor in solid tumour progression and therapeutic perspectives.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8b12ab08115b0843babff16a09d4714f"><gtr:id>8b12ab08115b0843babff16a09d4714f</gtr:id><gtr:otherNames>Roger S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F1443D45-D880-47DB-9E5E-692EBB707187"><gtr:id>F1443D45-D880-47DB-9E5E-692EBB707187</gtr:id><gtr:title>Identification of an intracellular microdomain of the P2X7 receptor that is crucial in basolateral membrane targeting in epithelial cells.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/de174d17e66c432ad3ad6af74e2bd039"><gtr:id>de174d17e66c432ad3ad6af74e2bd039</gtr:id><gtr:otherNames>Bradley HJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/C517317/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>